President Donald Trump wants to remake the Food and Drug Administration. And he happens to have a “fantastic person” in mind to do it, he said Tuesday — someone who will turn the agency into an industry-friendly shop that cranks out new cures on the double.

But does anyone really want a deregulated FDA? STAT canvassed biopharma insiders, physicians, Wall Street analysts, and FDA veterans. Their verdict: Trump’s plan sounds like a solution in search of a problem.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • If Trump can bring sweeping changes in the structure of FDA and a FDA Moderation Act to make medicines available to patients at affordable price, it will be welcome with open arms. Deregulation cannot happen – however, moderation can. Medicines require regulation but with well defined stages of regulation. Drug Development studies should be done with cell lines and not on human beings. Our science has advanced so much that new technologies can be introduced for drug development – cutting development cost and time. FDA should have experts from industry coopted for special task force teams for the Moderation Act.

  • très bonne chose pour les patients en train de mourir sans aucun espoir, pour ces gens là, un jour compte, une heure même un e minute
    Pour des fonctionnaires de la FDA, ils ont tout leur temps, pourquoi prendrait-il me plus petit risque
    Trump a de la compassion, formidable président

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy